Abstract: A chemically temperable borosilicate glass article has a low boron content and a corresponding Na2O content. The articles have good diffusivities and hydrolytical resistance values. When chemically tempered, the borosilicate glass article exhibits a compressive stress CS >400 MPa and a penetration depth DoL >20 ?m. A pharmaceutical primary packaging including the borosilicate glass article is also disclosed.

Abstract: A method for producing a glass article having high hydrolytic resistance is provided. A glass tube consisting of borosilicate glass and having an Al2O3 content of less than 1 weight-%, a ZrO2 content of 2-12 weight-%, and a glass transition temperature Tg is reshaped into a glass article and is subsequently subjected to a thermal post-treatment. To reduce the alkali release of the glass article, the glass article is subjected to a treatment temperature of TB?Tg+5° K over a treatment time of tB?5 min and is subsequently cooled during the thermal post-treatment.

Abstract: A glass having a good hydrolytic resistance and alkali resistance is defined by a targeted combination of stoichiometric glasses, including glasses also existing as crystals in the same stoichiometry and whose properties can be assumed as being very similar due to the identical topology of the structural units for glass and crystal, respectively. A process of producing the glasses is also provided.

Abstract: The invention relates to a process for producing alkali metal-rich aluminosilicate glasses having a content (in mol % based on oxide) of alkali metal oxides of 4-16 mol %, of Al2O3 of at least 4 mol % and of B2O3 of 0-4 mol %, wherein 0.15 mol % to 0.9 mol % of chloride(s) and at least one refining agent from the group of sulfate(s) (reported as SO3), CeO2 are added to the glass batch and wherein the sum total of refining agents added in the batch is 0.17 mol % to 1.3 mol %.

Abstract: An aluminum-free borosilicate glass includes the following glass composition (in weight-% on oxide basis): 70-80 SiO2; 8-14 B2O3; 0 Al2O3; 0-4 Na2O; 3-10 K2O; 0 Li2O; 3-14 sum Na2O+K2O; 0-1 CaO; 0-1 MgO; 0-1 BaO; 0-1 SrO; 0-2 sum CaO+MgO+BaO+SrO; 0-1 ZnO; 3.6-14 ZrO2; 0-10 TiO2; and 0.01-2.0 one or more refining agents, the weight ratio of ZrO2:K2O being in a range of 1.2:1 to 1.4:1.

Abstract: A chemically temperable borosilicate glass article has a low boron content and a corresponding Na2O content. The articles have good diffusivities and hydrolytical resistance values. When chemically tempered, the borosilicate glass article exhibits a compressive stress CS >400 MPa and a penetration depth DoL >20 ?m. A pharmaceutical primary packaging including the borosilicate glass article is also disclosed.

Abstract: A method for producing a glass article having high hydrolytic resistance is provided. A glass tube consisting of borosilicate glass and having an Al2O3 content of less than 1 weight-%, a ZrO2 content of 2-12 weight-%, and a glass transition temperature Tg is reshaped into a glass article and is subsequently subjected to a thermal post-treatment. To reduce the alkali release of the glass article, the glass article is subjected to a treatment temperature of TB?Tg+5° K over a treatment time of tB?5 min and is subsequently cooled during the thermal post-treatment.

Abstract: A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2: 5 9-84, Al2O3: 7-18.5, CaO: 1-25, SrO: 0-6.5, BaO: 0-5, ZrO2: 0-3, TiO2: 0-5, B2O3: 0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3<2.8, wherein the ratio (CaO+SrO+BaO)/SiO2?0.39, wherein the hydrolytic resistance according to DIN ISO 720 is class HGA 1, and wherein the glass, apart from unavoidable contaminations, is free of alkali oxides and magnesium oxides.

Abstract: The invention relates to a process for producing alkali metal-rich aluminosilicate glasses having a content (in mol % based on oxide) of alkali metal oxides of 4-16 mol %, of Al2O3 of at least 4 mol % and of B2O3 of 0-4 mol %, wherein 0.15 mol % to 0.9 mol % of chloride(s) and at least one refining agent from the group of sulfate(s) (reported as SO3), CeO2 are added to the glass batch and wherein the sum total of refining agents added in the batch is 0.17 mol % to 1.3 mol %.

Abstract: A glass having a good hydrolytic resistance and alkali resistance is defined by a targeted combination of stoichiometric glasses, including glasses also existing as crystals in the same stoichiometry and whose properties can be assumed as being very similar due to the identical topology of the structural units for glass and crystal, respectively. A process of producing the glasses is also provided.

Abstract: An aluminum-free borosilicate glass includes the following glass composition (in weight-% on oxide basis): 70-80 SiO2; 8-14 B2O3; 0 Al2O3; 0-4 Na2O; 3-10 K2O; 0 Li2O; 3-14 sum Na2O+K2O; 0-1 CaO; 0-1 MgO; 0-1 BaO; 0-1 SrO; 0-2 sum CaO+MgO+BaO+SrO; 0-1 ZnO; 3.6-14 ZrO2; 0-10 TiO2; and 0.01-2.0 one or more refining agents, the weight ratio of ZrO2:K2O being in a range of 1.2:1 to 1.4:1.

Abstract: A zirconium-free neutral glass is provided that finds use in the pharmaceutical sector. The glass has a combination of alkali metal oxides of sodium, potassium and optionally lithium, and a controlled amount of aluminum oxide, which provides a zirconium-free and low-boron neutral glass having good hydrolytic stability, good acid and alkali stability and good devitrification properties. The glass includes the following components in % by weight: SiO2 ?72-82, B2O3 ??3-8, Al2O3 ??5-8, Na2O 2.5-5.5, K2O 3.6-8.4, Li2O ??0-0.7, MgO ??0-0.7, CaO ??0-0.4, and TiO2 ??0-5, wherein Li2O + Na2O + K2O 6.8-14.6, and K2O/Na2O ratio 0.7-3.4.

Abstract: A pharmaceutical packaging is provided including a glass, comprising at least the following components (given in mol % on oxide basis): SiO2:59-84, Al2O3:7-18.5, CaO:1-25, SrO:0-6.5, BaO:0-5, ZrO2:0-3, TiO2:0-5, B2O3:0-1, wherein the ratio (CaO+SrO+BaO)/Al2O3<2.8, wherein the ratio (CaO+SrO+BaO)/SiO2?0.39, wherein the hydrolytic resistance according to DIN ISO 720 is class HGA 1, and wherein the glass, apart from unavoidable contaminations, is free of alkali oxides and magnesium oxides.

Abstract: Borosilicate glasses, preferably for use in the pharmaceutical sector, are provided. The borosilicate glasses are outstandingly suitable for the use as pharmaceutical primary packaging, such as phials or ampoules, since the aqueous or water-containing medicaments kept in the containers do not attack the glass significantly, and so the glass releases no, or only few, ions. The borosilicate glasses have the following composition in % by weight or consist thereof: SiO2 71-77; B2O3 9-12; Al2O3 5.5-8; Na2O 6-8; K2O 0.1-0.9; Li2O 0-0.3; CaO 0-1.5; BaO 0-1; F 0-0.3; Cl- 0-0.3; and MgO + CaO + BaO + SrO 0-2.

Abstract: A zirconium-free neutral glass is provided that finds use in the pharmaceutical sector. The glass has a combination of alkali metal oxides of sodium, potassium and optionally lithium, and a controlled amount of aluminium oxide, which provides a zirconium-free and low-boron neutral glass having good hydrolytic stability, good acid and alkali stability and good devitrification properties. The glass includes the following components in % by weight: SiO2 ?72-82, B2O3 ??3-8, Al2O3 ??5-8, Na2O 2.5-5.5, K2O 3.6-8.4, Li2O ??0-0.7, MgO ??0-0.7, CaO ??0-0.4, and TiO2 ??0-5, wherein Li2O + Na2O + K2O 6.8-14.6, and K2O/Na2O ratio 0.7-3.4.

Abstract: A process for producing glass tubes is provided that includes: applying a glass melt onto the outer surface of a rotating cylindrical shaping body to form thereon a hollow glass melt body; and withdrawing the hollow glass melt body over the shaping body toward a front end for forming a glass tube; wherein the shaping body is coated with platinum or a platinum alloy in regions that are in contact with the glass melt. The glass melt has a composition in wt.-% of: SiO2 71.0 to 77.0; B2O3 9.0 to 12.0; Na2O 5.5 to 8.0; K2O 0.0 to 2.0; Al2O3 6.5 to 8.0; CaO 0.0 to 1.5; BaO 0.0 to 2.0; Li2O 0.0 to 0.5; ZrO2 0.0 to 5.0. The glass composition provides enhanced devitrification characteristics so that glass tubes can be drawn using a Danner mandrel that is coated with platinum or a platinum alloy.

Abstract: A borosilicate glass is provided that has high solarization resistance and a defined position of the UV edge. The borosilicate glass includes the following constituents, in percent by weight based on oxide, of: SiO2 65-85%; B2O3 7-20%; Al2O3 0-7%; Li2O 0-2%; Na2O 0-8%; K2O 0-12%; BaO 0-5%; CaO 0-2%; MgO 0-2%; ZnO 0-2%; TiO2 0.05-0.4%; MoO3 0.025-0.3%; and V2O5 0.001-0.01%.

Abstract: A photovoltaic cell, for example a thin-film photovoltaic cell, having a substrate glass made of aluminosilicate glass, has a glass composition which has SiO2 and Al2O3 as well as the alkali metal oxide Na2O and the alkaline earth oxides CaO, MgO, and BaO, and optionally further components. The glass composition includes 10 to 16 wt.-% Na2O, >0 to <5 wt.-% CaO, and >1 to 10 wt.-% BaO, and the ratio of CaO:MgO is in the range of 0.5 to 1.7. The aluminosilicate glass used is crystallization stable because of the selected quotient of CaO/MgO and has a transformation temperature >580° C. and a processing temperature <1200° C. Therefore, it represents a more thermally stable alternative to soda-lime glass. The aluminosilicate glass is used as a substrate glass, superstrate glass, and/or cover glass for a photovoltaic cells, for example for thin-film photovoltaic cells, in particular those based on semiconductor composite material, such as CdTe, CIS, or CIGS.

Abstract: Borosilicate glasses, preferably for use in the pharmaceutical sector, are provided. The borosilicate glasses are outstandingly suitable for the use as pharmaceutical primary packaging, such as phials or ampoules, since the aqueous or water-containing medicaments kept in the containers do not attack the glass significantly, and so the glass releases no, or only few, ions. The borosilicate glasses have the following composition in % by weight or consist thereof: SiO2 71-77; B2O3 9-12; Al2O3 5.5-8; Na2O 6-8; K2O 0.1-0.9; Li2O 0-0.3; CaO 0-1.5; BaO 0-1; F 0-0.3; Cl- 0-0.3; and MgO + CaO + BaO + SrO 0-2.

Abstract: The invention relates to an alumino-silicate glass which has a thermal expansion coefficient in the range of 8 to 10×10?6/K in a temperature range of 20 to 300° C., a transformation temperature Tg in a range of 580° C. to 640° C., and a processing temperature VA in a range of 1065° C. to 1140° C. and which can therefore be used as an alternative for soda lime glasses. An object of the invention is also the use of the inventive glasses in applications where a high temperature stability of the glasses is advantageous, in particular as substrate glass, superstrate glass and/or cover glass in the field of semiconductor technology, preferably for Cd—Te or for CIS or CIGS photovoltaic applications and for other applications in solar technology.